Why the study?
To review important British contributions to cardiac surgery for congenital heart disease and consider future challenges, specifically managing and reducing adverse surgical sequelae through safe innovation.
Cardiac surgery has transformed the prognosis of congenital heart disease, enabling over 90% of affected children to survive into adulthood.
High survival in congenital heart disease survivors highlights need to mitigate sequelae; leaves open optimal innovation strategies.
The success of cardiac surgery has transformed the prospects of children with congenital heart disease with over 90% now surviving to adulthood. The early pioneering surgeons took on significant risk, whilst current surgical practice emphasises safety and consistency. In this article we review important British contributions to the field and consider challenges for the future, specifically how to better manage and reduce the adverse sequelae of congenital cardiac surgery by continuing to innovate safely.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: